Clinical Trial Update: Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated primary vaccination with a pneumococcal conjugate vaccine in healthy infants aged 6 to 10 weeks; study completed with posted results i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infections Caused By Streptococcus Pneumoniae
• Streptococcus Pneumoniae Infections

Drugs mentioned

• Pneumococcal conjugate vaccine (pneumococcal conjugate vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal, Streptococcus Pneumoniae | Phase 3 | Status: COMPLETED | Results posted: 2010-10-29